683 Capital Management’s IN8bio INAB Stock Holding History

683 Capital Management’s Portfolio INAB Stock Details INAB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.02M	Hold	724,637	–	–	0.05%	122
2026 Q1	$1.07M	Hold	724,637	–	–	0.06%	135
2025 Q4	$1.7M	Buy	+724,637	New	+$1.38M	0.07%	112
2025 Q1	–	Sell	-25,000	Closed	-$193K	–	195
2024 Q4	$193K	Sell	25,000 -20,010	-44%	-$176K	0.01%	212
2024 Q3	$365K	Buy	45,010 +25,316	+129%	+$459K	0.03%	110
2024 Q2	$500K	Sell	19,694 -798	-4%	-$25.6K	0.04%	106
2024 Q1	$725K	Hold	20,492	–	–	0.05%	94
2023 Q4	$848K	Buy	+20,492	New	+$655K	0.07%	94

Other funds holding INAB

Alyeska Investment Group Chicago, Illinois $38.9B AUM 28.51% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

SCM

Stonepine Capital Management Bend, Oregon $177M AUM 91.13% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

BCM

BIOS Capital Management Fort Worth, Texas $41.7M AUM 34.92% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return

Oppenheimer & Co New York $9.37B AUM 36.4% 1-Year Est. Return

Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM

CAPTRUST Financial Advisors Raleigh, North Carolina $65.5B AUM 24.25% 1-Year Est. Return

683 Capital Management's INAB Position: Q2 2026 in Review

683 Capital Management held its IN8bio (INAB) position steady in Q2 2026 at 724,637 shares worth $1.02M. The position accounts for 0.05% of the portfolio, ranked #122.

683 Capital Management first reported a position in INAB in Q4 2023 and has held it in 8 quarters since. The position peaked at $1.7M in Q4 2025. 21 funds tracked by Wall St. Rank hold INAB as of Q2 2026.

683 Capital Management held 724,637 shares of IN8bio worth $1.02M as of Q2 2026.
683 Capital Management left its IN8bio share count unchanged in Q2 2026.
IN8bio made up 0.05% of 683 Capital Management's portfolio in Q2 2026, its #122 holding.
683 Capital Management first reported a position in IN8bio in Q4 2023 and has held it in 8 quarters since.
683 Capital Management's IN8bio position peaked at $1.7M in Q4 2025.
21 funds tracked by Wall St. Rank held IN8bio as of Q2 2026.

Based on 683 Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.